Arkolith/Insider Trading/PBSV/Form 4

Lasanta Pedro J

Chief Financial OfficerPharma-Bio Serv, Inc. (PBSV) · full profile →Form 4 · filed Mar 8, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 6, 2023Tax withholding(F)77K$1.15$88K118K
Mar 6, 2023Option exercise(M)100K$0.88$88K195K
Mar 6, 2023Tax withholding(F)7K$1.15$8K119K
Mar 6, 2023Option exercise(M)8K$0.99$8K126K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 6, 2023Option exercise(M)8K—$017K
Mar 6, 2023Option exercise(M)100K—$00

Transaction Codes

F
Shares withheld for taxes
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001654954-23-002543) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML